This episode examines aminoglycosides as the pharmacology of high-impact precision. These drugs deliver fast, concentration-dependent bactericidal action against serious Gram-negative infections, yet their usefulness is constrained by predictable and serious toxicity. We explore ribosomal binding, oxygen-dependent uptake, post-antibiotic effect, and syn…

This episode explores β-lactam antibiotics as the pharmacology of structural sabotage. By targeting cell wall synthesis-a feature humans do not possess-penicillins, cephalosporins, carbapenems, and related agents achieve extraordinary selective toxicity. We trace peptidoglycan assembly, penicillin-binding proteins, and bacterial autolysis to explain why…

Episode description (with key takeaways)This episode tackles sulfonamides, trimethoprim–sulfamethoxazole, quinolones, and urinary-tract–focused agents as the pharmacology of broad reach. These drugs are versatile, familiar, and effective-precisely why they demand disciplined use. We explore folate pathway inhibition, DNA gyrase/topoisomerase targeting, …

This episode examines antihelminthic therapy as the pharmacology of selective vulnerability. Helminths are biologically sophisticated, multicellular organisms-far closer to us than bacteria-yet they harbour unique neuromuscular and metabolic features that drugs can exploit. We explore mechanisms that paralyse, starve, or dislodge worms, and why cure oft…

This episode expands antimicrobial thinking beyond malaria to the diverse world of protozoal infections-amebiasis, giardiasis, trichomoniasis, leishmaniasis, trypanosomiasis, and beyond. The unifying lesson is diversity: protozoa share a kingdom, not a strategy. We explore metabolic vulnerabilities, tissue tropism, intracellular sanctuaries, and host–pa…

This episode explores antimalarial therapy as the pharmacology of adaptation versus evasion. Plasmodium changes form, habitat, and vulnerability as it moves between liver, blood, and mosquito-forcing drugs to be chosen not just by species, but by life stage and geography. We trace haem detoxification, folate antagonism, mitochondrial targets, and artemi…

This episode lays the foundation for all antimicrobial pharmacology by reframing antibiotics as ecological interventions. Every prescription alters not only the target pathogen but also the host, the microbiome, and the wider microbial environment. We explore principles of selective toxicity, bactericidal versus bacteriostatic action, resistance mechani…

This episode explores inflammatory bowel disease as the pharmacology of misdirected defence. In ulcerative colitis and Crohn’s disease, immune mechanisms designed to protect the intestinal barrier instead sustain injury over time. We examine cytokine signalling, epithelial integrity, microbiome interaction, and immune tolerance to understand why IBD is …

This episode examines gastrointestinal motility and fluid handling as the pharmacology of directed movement. From oesophageal peristalsis to colonic propulsion, from secretion to absorption, the gut is a finely tuned conveyor system. We explore the enteric nervous system, smooth-muscle signalling, and epithelial transport to understand disorders of diar…

This episode explores gastric acidity and mucosal defence as the pharmacology of controlled corrosion. Acid is essential for digestion and defence, yet devastating when it escapes its boundaries. We examine parietal cell physiology, acid secretion pathways, and the layered protective mechanisms of the upper gastrointestinal tract to understand peptic ul…